Trupanion (NASDAQ:TRUP – Get Free Report) will issue its quarterly earnings data after the market closes on Thursday, May 2nd. Analysts expect the company to announce earnings of ($0.18) per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link.
Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings data on Thursday, February 15th. The financial services provider reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.13. Trupanion had a negative return on equity of 15.19% and a negative net margin of 4.03%. The firm had revenue of $295.50 million during the quarter, compared to analysts’ expectations of $289.84 million. During the same quarter in the prior year, the business posted ($0.23) earnings per share. Trupanion’s revenue was up 20.1% compared to the same quarter last year. On average, analysts expect Trupanion to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Trupanion Stock Performance
Shares of TRUP stock opened at $22.50 on Wednesday. Trupanion has a fifty-two week low of $18.45 and a fifty-two week high of $37.71. The business has a fifty day simple moving average of $25.68 and a 200-day simple moving average of $26.81. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.63.
Analysts Set New Price Targets
Read Our Latest Stock Analysis on Trupanion
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also
- Five stocks we like better than Trupanion
- What Does a Stock Split Mean?
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Hilton Demonstrates Asset Light is Right for Investors
- How to buy stock: A step-by-step guide for beginners
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.